AplusA

Doctors Professional vs Personal Use of New Technology

Healthcare Industry, Digital

The healthcare industry is attempting to keep up with the speed at which new technologies are being...

How Will Connected Devices Impact the Future of Healthcare?

Healthcare Industry, Digital

Ninety-nine percent of young, French health care practitioners have a smartphone and 94% of them...

Doctors and New Technology: The Slow Adopters

Patients, Digital

The development of digital technology in healthcare shows no signs of slowing down. Certain...

What are The Effects of Technology According to Doctors in France and the UK?

Patients, Digital

New digital technologies impact our personal and professional lives daily. Medical professionals...

Who Are The Key Hemato-Oncology Market Stakeholders?

Healthcare Industry, hemato-oncology, Oncology

As a marketing professional in the healthcare industry, you need to accurately identify the...

Who are the Digital Opinion Leaders in Hemato-Oncology?

Healthcare Industry, Digital, hemato-oncology

KOLs (Key Opinion Leaders) have long since played an important and influential role in the...

5 Benefits of Syndicated Research in the Hematology Oncology Market

Healthcare Industry, Market Research Industry, hemato-oncology, Syndicated Studies

In the rapidly evolving onco -hematology market, syndicated research provides critical insights...

DLBCL Treatment: A Quick Overview

hemato-oncology, DLBCL market, Syndicated Studies, Oncology

DLBCL is the most common form of non-Hodgkin’s lymphoma (NHL), constituting 30% to 58% of lymphoma...

Why is the Hemato-Oncology Market Complex for Market Researchers?

hemato-oncology, Tracking Studies, Syndicated Studies, Oncology

The hematology oncology market is one of the most rapidly developing, with over sixty oncology...

Chronic Lymphocytic Leukemia: Current and Future CLL Treatments

hemato-oncology, Tracking Studies, Syndicated Studies, Oncology

Chronic Lymphocytic Leukemia is the most common form of leukemia in Western countries. Although...